Compare INUV & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INUV | CDIO |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | 51 | N/A |
| Industry | Advertising | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3M | 6.1M |
| IPO Year | 1996 | 2021 |
| Metric | INUV | CDIO |
|---|---|---|
| Price | $0.27 | $1.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 71.1K | 15.3K |
| Earning Date | 11-12-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $86,209,305.00 | $14,825.00 |
| Revenue This Year | N/A | $168,534.06 |
| Revenue Next Year | $12.51 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.88 | N/A |
| 52 Week Low | $0.38 | $0.97 |
| 52 Week High | $3.80 | $7.91 |
| Indicator | INUV | CDIO |
|---|---|---|
| Relative Strength Index (RSI) | 20.99 | 61.67 |
| Support Level | N/A | $1.72 |
| Resistance Level | $0.50 | $2.20 |
| Average True Range (ATR) | 0.04 | 0.11 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 13.67 | 70.30 |
Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.